Published in J Cell Biol on March 01, 1996
Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell (2008) 4.17
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A (2003) 3.40
Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A (2002) 3.03
Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A (2004) 2.98
Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest (2003) 2.40
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest (2000) 2.33
A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci U S A (2006) 2.32
Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol (2005) 2.30
A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol (1997) 2.20
Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest (1998) 2.04
Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol (2008) 1.91
Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol (1997) 1.74
Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol (2001) 1.74
Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci U S A (2005) 1.72
5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest (2005) 1.62
Smad2 and myocardin-related transcription factor B cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ Res (2013) 1.58
A novel in vitro model system for smooth muscle differentiation from human embryonic stem cell-derived mesenchymal cells. Am J Physiol Cell Physiol (2012) 1.57
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A (2001) 1.48
Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods (2013) 1.46
Cell-specific nuclear import of plasmid DNA. Gene Ther (1999) 1.44
Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest (1997) 1.37
Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. Proc Natl Acad Sci U S A (2009) 1.30
Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-γ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation (2012) 1.30
Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res (2010) 1.29
Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol (2005) 1.25
The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest (2000) 1.21
HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol Cell Biol (2004) 1.18
Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res (2012) 1.16
Lost in transgenesis: a user's guide for genetically manipulating the mouse in cardiac research. Circ Res (2012) 1.14
Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J Cell Biol (2008) 1.14
Target gene-specific modulation of myocardin activity by GATA transcription factors. Mol Cell Biol (2004) 1.13
PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol Cell Biol (2005) 1.09
The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem (2009) 1.06
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med (2012) 1.06
Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo. Circ Res (2012) 1.01
Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am J Physiol Cell Physiol (2006) 0.99
Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element. Am J Pathol (2005) 0.99
Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Mol Endocrinol (2011) 0.97
Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity. J Biol Chem (2010) 0.95
Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels. Mol Cell Biol (2009) 0.91
Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am J Physiol Heart Circ Physiol (2010) 0.90
Telokin expression is restricted to smooth muscle tissues during mouse development. Am J Physiol Cell Physiol (2001) 0.90
Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3. PLoS One (2012) 0.90
Smooth muscle calponin: an unconventional CArG-dependent gene that antagonizes neointimal formation. Arterioscler Thromb Vasc Biol (2011) 0.90
Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest (1997) 0.88
Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells. J Cell Biol (1997) 0.88
Phylogeny informs ontogeny: a proposed common theme in the arterial pole of the vertebrate heart. Evol Dev (2010) 0.88
Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc Natl Acad Sci U S A (2007) 0.88
Numb family proteins are essential for cardiac morphogenesis and progenitor differentiation. Development (2013) 0.87
Disruption of actin cytoskeleton mediates loss of tensile stress induced early phenotypic modulation of vascular smooth muscle cells in organ culture. Exp Mol Pathol (2009) 0.87
Sm22α transcription occurs at the early onset of the cardiovascular system and the intron 1 is dispensable for its transcription in smooth muscle cells during mouse development. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Notch1 activation in embryonic VE-cadherin populations selectively blocks hematopoietic stem cell generation and fetal liver hematopoiesis. Transgenic Res (2012) 0.86
Transgenic mice for cGMP imaging. Circ Res (2013) 0.86
Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues. Br J Pharmacol (2008) 0.86
In vivo expression of a conditional TGF-beta1 transgene: no evidence for TGF-beta1 transgene expression in SM22alpha-tTA transgenic mice. J Mol Cell Cardiol (2005) 0.85
Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats. Biochem J (2003) 0.85
Changing topographic Hox expression in blood vessels results in regionally distinct vessel wall remodeling. Biol Open (2012) 0.85
Transitions in cell organization and in expression of contractile and extracellular matrix proteins during development of chicken aortic smooth muscle: evidence for a complex spatial and temporal differentiation program. Anat Embryol (Berl) (1998) 0.84
Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding. J Biol Chem (2008) 0.83
Proteomic analysis of pubocervical fascia in women with and without pelvic organ prolapse and urodynamic stress incontinence. Int Urogynecol J (2010) 0.83
Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Atherosclerosis (2010) 0.82
Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice. J Mol Cell Cardiol (2011) 0.82
A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase. Genesis (2009) 0.82
Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation. Toxicol Lett (2010) 0.81
Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus. Circ Res (2015) 0.81
Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice. Am J Pathol (2015) 0.81
Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade. Proc Natl Acad Sci U S A (2015) 0.81
Molecular cloning and characterization of murine caspase-12 gene promoter. Proc Natl Acad Sci U S A (2005) 0.81
Fishing for function: zebrafish BAC transgenics for functional genomics. Mol Biosyst (2011) 0.80
Construction of vascular tissues with macro-porous nano-fibrous scaffolds and smooth muscle cells enriched from differentiated embryonic stem cells. PLoS One (2012) 0.80
Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype. J Neurogastroenterol Motil (2015) 0.80
Intronic CArG box regulates cysteine-rich protein 2 expression in the adult but not in developing vasculature. Arterioscler Thromb Vasc Biol (2010) 0.80
Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice. Calcif Tissue Int (2012) 0.79
TGFβ1-induced Baf60c regulates both smooth muscle cell commitment and quiescence. PLoS One (2012) 0.78
Von Willebrand factor inhibits mature smooth muscle gene expression through impairment of Notch signaling. PLoS One (2013) 0.78
Correlative intravital imaging of cGMP signals and vasodilation in mice. Front Physiol (2014) 0.78
PIAS1 regulates CP2c localization and active promoter complex formation in erythroid cell-specific alpha-globin expression. Nucleic Acids Res (2010) 0.77
Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation. J Biol Chem (2016) 0.76
Smooth muscle CaMKIIδ promotes allergen-induced airway hyperresponsiveness and inflammation. Pflugers Arch (2015) 0.76
Purification and functional assessment of smooth muscle cells derived from mouse embryonic stem cells. J Geriatr Cardiol (2013) 0.75
Low levels of the reverse transactivator fail to induce target transgene expression in vascular smooth muscle cells. PLoS One (2014) 0.75
Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells. J Anat (2006) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
Chromatin as an essential part of the transcriptional mechanism. Nature (1992) 6.90
Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques (1988) 6.83
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91
MyoD family: a paradigm for development? Genes Dev (1990) 5.32
Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science (1995) 3.64
Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev (1990) 3.62
Characterization of a unique muscle cell line. J Cell Biol (1974) 3.53
The intima. Soil for atherosclerosis and restenosis. Circ Res (1995) 3.48
Neural crest cells contribute to normal aorticopulmonary septation. Science (1983) 3.44
Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev (1995) 3.16
Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. J Embryol Exp Morphol (1975) 3.13
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res (1996) 2.96
The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol (1990) 2.91
Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res (1994) 2.37
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol (1981) 2.33
Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol (1995) 2.28
Making muscle in mammals. Trends Genet (1992) 2.28
FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell (1992) 2.28
Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol (1995) 2.19
Developmental mechanisms underlying pathology of arteries. Physiol Rev (1990) 2.17
Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem (1995) 2.05
A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev Biol (1995) 1.98
Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem (1994) 1.96
Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res (1993) 1.88
Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc Natl Acad Sci U S A (1993) 1.76
Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoter. Mol Cell Biol (1988) 1.50
Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol (1992) 1.49
Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation (1993) 1.44
Expression of the atrial-specific myosin heavy chain AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. Development (1994) 1.31
The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem (1995) 1.29
Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem (1992) 1.20
Coronary artery development in the chick: origin and deployment of smooth muscle cells, and the effects of neural crest ablation. Anat Rec (1992) 1.17
Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. J Biol Chem (1987) 1.16
Characterization of the gene for mp20: a Drosophila muscle protein that is not found in asynchronous oscillatory flight muscle. J Cell Biol (1989) 1.14
Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle alpha-actin gene. J Biol Chem (1992) 1.13
Mapping of myogenin transcription during embryogenesis using transgenes linked to the myogenin control region. J Cell Biol (1992) 1.10
Electron microscopic study of the prenatal development of the thoracic aorta in the rat. Am J Anat (1988) 1.02
Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am J Physiol (1991) 1.00
Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest. Ann N Y Acad Sci (1990) 1.00
Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biol (1992) 0.98
Deletion analyses of 5'-flanking region of the human elastin gene. Delineation of functional promoter and regulatory cis-elements. J Biol Chem (1990) 0.95
Identification of functional promoter elements in the rabbit smooth muscle myosin heavy chain gene. J Biol Chem (1994) 0.92
The ultrastructure of embryonic myocardial blood vessels. Dev Biol (1971) 0.91
The identification of NP25: a novel protein that is differentially expressed by neuronal subpopulations. Brain Res Mol Brain Res (1994) 0.89
Vascularization of human endometrium. Uterine blood flow in healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci (1994) 0.88
Oxytocin and oxytocin receptor gene expression in the uterus. Recent Prog Horm Res (1995) 0.87
Diversification of cardiomyogenic cell lineages during early heart development. Circ Res (1995) 0.86
Differential protein expression in aortic smooth muscle cells cultured from newborn and aged rats. Exp Cell Res (1995) 0.83
Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. Exp Cell Res (1987) 0.82
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59
Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09
Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31
Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol (2003) 6.99
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev (1997) 6.52
Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell (1995) 6.24
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science (1997) 5.54
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell (2000) 5.13
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A (2000) 4.27
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A (2000) 4.08
Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet (1997) 3.89
Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest (2000) 3.70
Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science (1995) 3.64
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59
IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature (1999) 3.54
Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development (1994) 3.53
A genetic blueprint for cardiac development. Nature (2000) 3.45
The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1995) 3.38
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol Cell Biol (1988) 3.24
Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem (2000) 3.19
Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev (1990) 3.18
Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev (2001) 3.17
PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron (1998) 3.09
Acylation of proteins with myristic acid occurs cotranslationally. Science (1987) 3.08
Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res (2000) 3.04
Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02
SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res (1996) 2.96
Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol (1986) 2.90
Defining the regulatory networks for muscle development. Curr Opin Genet Dev (1996) 2.79
HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol (1992) 2.72
Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res (2001) 2.67
Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol (1992) 2.64
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Specificity of fatty acid acylation of cellular proteins. J Biol Chem (1985) 2.63
Requirement of the MADS-box transcription factor MEF2C for vascular development. Development (1998) 2.63
Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A (1993) 2.53
Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem (2001) 2.45
Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol (1991) 2.40
Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol (1996) 2.40
Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science (1998) 2.39
A subclass of bHLH proteins required for cardiac morphogenesis. Science (1995) 2.39
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38
Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res (1994) 2.37
Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science (1993) 2.36
Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci U S A (2000) 2.33
Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol (2001) 2.32
Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development (1999) 2.30
A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol Cell Biol (1994) 2.30
FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell (1992) 2.28
HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol (1999) 2.27
D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc Natl Acad Sci U S A (1994) 2.26
Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development (1999) 2.24
Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol (1997) 2.23
Decoding calcium signals involved in cardiac growth and function. Nat Med (2000) 2.23
Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol (1995) 2.19
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J (2001) 2.19
Wingless signaling induces nautilus expression in the ventral mesoderm of the Drosophila embryo. Dev Biol (1996) 2.13
Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem (1993) 2.10
Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci (1995) 2.10
Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc Natl Acad Sci U S A (1991) 2.08
Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J Biol Chem (1986) 2.08
The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev (1995) 2.07
Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci U S A (2000) 2.05
PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol (1995) 2.05
Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development (1995) 1.99
A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev Biol (1995) 1.98
Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat Genet (1998) 1.98
The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol (1987) 1.95
Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev (1992) 1.92
Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics (2000) 1.89
Building the heart piece by piece: modularity of cis-elements regulating Nkx2-5 transcription. Development (1999) 1.88
Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev (1995) 1.85
Identification of a prx1 limb enhancer. Genesis (2000) 1.83
Antisocial, an intracellular adaptor protein, is required for myoblast fusion in Drosophila. Dev Cell (2001) 1.83
Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol Cell Biol (1998) 1.82
Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding. Mol Cell Biol (1991) 1.79
Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha. J Biol Chem (1997) 1.78
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc Natl Acad Sci U S A (2001) 1.76
The bHLH transcription factor dHAND controls Sonic hedgehog expression and establishment of the zone of polarizing activity during limb development. Development (2000) 1.76
Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol (1995) 1.74
A signaling cascade involving endothelin-1, dHAND and msx1 regulates development of neural-crest-derived branchial arch mesenchyme. Development (1998) 1.71
Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev (1998) 1.71
Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells. J Biol Chem (1983) 1.70
The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development (2001) 1.69
FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol Cell Biol (1999) 1.69
Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev Biol (1995) 1.68